This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,929.48 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 15, 2024. The contract is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,353.52 and an ultimate completion date of December 18, 2024. It is a Delivery Order under a Firm Fixed Price contract type. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,800.16 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024, with a completion date of July 18, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 16, 2025 with a ceiling value of $1,474.20 and an ultimate completion date of January 17, 2025. The award is a delivery order contract, with a firm fixed price pricing type. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $7,372.42 firm fixed price delivery order was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024. The contract has a completion date of November 14, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,626.92 and is a firm fixed-price delivery order with an ultimate completion date of October 21, 2024. This contract is associated with a larger Indefinite Delivery...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,132.12 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 29, 2022, with a completion date of June 30, 2022. The contract is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,900.08 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 9, 2024. It is not designated as a set-aside contract....
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency, by Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $1,900.08 and a completion date of May 24, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $12,246.66, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...